These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia. Emanuel PD, Bates LJ, Zhu SW, Castleberry RP, Gualtieri RJ, Zuckerman KS. Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702 [Abstract] [Full Text] [Related]
3. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture. Sawai N, Koike K, Ito S, Okumura N, Kamijo T, Shiohara M, Amano Y, Tsuji K, Nakahata T, Oda M. Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332 [Abstract] [Full Text] [Related]
4. Central role of tumour necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia. Freedman MH, Cohen A, Grunberger T, Bunin N, Luddy RE, Saunders EF, Shahidi N, Lau A, Estrov Z. Br J Haematol; 1992 Jan; 80(1):40-8. PubMed ID: 1311195 [Abstract] [Full Text] [Related]
5. Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors. Piacibello W, Sanavio F, Severino A, Morelli S, Vaira AM, Stacchini A, Aglietta M. Cancer Res; 1990 Aug 15; 50(16):5065-71. PubMed ID: 1696165 [Abstract] [Full Text] [Related]
9. Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligand. Strife A, Perez A, Lambek C, Wisniewski D, Bruno S, Darzynkiewicz Z, Clarkson B. Cancer Res; 1993 Jan 15; 53(2):401-9. PubMed ID: 7678076 [Abstract] [Full Text] [Related]
10. Differentiation-inducing effect of recombinant human tumor necrosis factor alpha and gamma-interferon in vitro on blast cells from patients with acute myeloid leukemia and myeloid blast crisis of chronic myeloid leukemia. Geissler K, Tricot G, Leemhuis T, Walker E, Broxmeyer HE. Cancer Res; 1989 Jun 01; 49(11):3057-62. PubMed ID: 2497971 [Abstract] [Full Text] [Related]
11. Cellular characteristics of chronic myelocytic leukemia basophilic crisis cells: phenotype, responsiveness to and receptor gene expression for various kinds of growth factors and cytokines. Shimizu N, Kita K, Masuya M, Nishii K, Matsuoka N, Morita N, Miwa H, Shirakawa S. Exp Hematol; 1993 Jan 01; 21(1):119-25. PubMed ID: 7678084 [Abstract] [Full Text] [Related]
12. Human granulocyte-macrophage colony-stimulating factor supports the clonogenic growth of B-lineage acute lymphoblastic leukemias expressing myeloid antigens. Gattei V, Aldinucci D, Attadia V, Degan M, Alosi MS, De Iuliis A, Babare R, Rossi FM, Rupolo M, Zagonel V, Pinto A. Cytokines Cell Mol Ther; 1997 Sep 01; 3(3):141-51. PubMed ID: 9426972 [Abstract] [Full Text] [Related]
13. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells. Ferret-Bernard S, Saï P, Bach JM. Immunol Lett; 2004 Feb 15; 91(2-3):221-7. PubMed ID: 15019293 [Abstract] [Full Text] [Related]
14. Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cells. Beran M, O'Brien S, Andersson B, McCredie KB, Gutterman JU. Hematol Pathol; 1988 Feb 15; 2(2):65-71. PubMed ID: 3143710 [Abstract] [Full Text] [Related]
15. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood. Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ. Exp Hematol; 1997 Oct 15; 25(11):1125-39. PubMed ID: 9328449 [Abstract] [Full Text] [Related]
16. Juvenile chronic myelogenous leukemia: in vitro characterization before and after allogeneic bone marrow transplantation. Zecca M, Rosti V, Pinto L, Comoli P, Carrà AM, Prete L, Bonetti F, Pedrazzoli P, Locatelli F, Cazzola M. Med Pediatr Oncol; 1995 Mar 15; 24(3):166-70. PubMed ID: 7838038 [Abstract] [Full Text] [Related]
17. Thrombopoietin enhances the production of myeloid cells, but not megakaryocytes, in juvenile chronic myelogenous leukemia. Sawai N, Koike K, Higuchi T, Ogami K, Oda M. Blood; 1998 Jun 01; 91(11):4065-73. PubMed ID: 9596651 [Abstract] [Full Text] [Related]
18. Induction of fibroblast-like cells from CD34(+) progenitor cells of the bone marrow in rheumatoid arthritis. Hirohata S, Yanagida T, Nagai T, Sawada T, Nakamura H, Yoshino S, Tomita T, Ochi T. J Leukoc Biol; 2001 Sep 01; 70(3):413-21. PubMed ID: 11527991 [Abstract] [Full Text] [Related]
19. Cell culture studies and oncogene expression in juvenile chronic myelogenous leukemia. Gualtieri RJ, Castleberry RP, Gibbons J, Miller DM, Berkow RL, Parmley RT, Banks J. Exp Hematol; 1988 Aug 01; 16(7):613-9. PubMed ID: 2968914 [Abstract] [Full Text] [Related]
20. Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines. Muszynski KW, Ruscetti FW, Gooya JM, Linnekin DM, Keller JR. Stem Cells; 1997 Aug 01; 15(1):63-72. PubMed ID: 9007224 [Abstract] [Full Text] [Related] Page: [Next] [New Search]